TREA

79201532 - BEGESAND

Follow

Information

  • Trademark
  • 79201532
  • Serial Number
    79201532
  • Registration Number
    5372122
  • Filing Date
    September 08, 2016
    8 years ago
  • Registration Date
    January 09, 2018
    7 years ago
  • Transaction Date
    September 03, 2024
    4 months ago
  • Status Date
    July 26, 2024
    5 months ago
  • Published for Opposition Date
    October 24, 2017
    7 years ago
  • Location Date
    January 09, 2018
    7 years ago
  • Status Code
    709
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    TWOHIG,SHANNON MARIE
  • Attorney Docket Number
    2795.0130000
    Attorney Name
    Monica Riva Talley
    Law Office Assigned Location Code
    L50
  • Owners
Information
Mark Drawing Code
4
Mark Identification
BEGESAND
Case File Statements
  • GS0051: Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer, for the prevention and treatment of cancer, for the treatment of immune system related diseases and disorders; medical preparations for the treatment of viral and infectious diseases, for the treatment of cancer, for the prevention and treatment of cancer, for the treatment of immune system related diseases and disorders; and veterinary preparations for the treatment of viral and infectious diseases, for the treatment of cancer, for the prevention and treatment of cancer, for the treatment of immune system related diseases and disorders; sanitary preparations for medical purposes; dietetic food for treating viral and infectious diseases, for treating cancer, for treating immune system related diseases and disorders, for the prevention and treatment of cancer, and substances in the nature of beverages for medical or veterinary use; monoclonal antibodies and antibody mixtures for medical use, namely, diagnostic kits consisting primarily of monoclonal antibodies for use in disease testing; monoclonal antibodies for immunomodulatory treatments, in particular for the treatment of diseases mediated by the differentiation cluster 26 molecule CD26; pharmaceutical preparations comprising as active ingredient monoclonal antibodies having immunomodulatory effects, in particular for the treatment of diseases mediated by the 26 differentiation cluster molecule CD26; dietetic foods, namely, yogurt and rice-derived products, namely, rice flour adapted for medical use, dietetic beverages adapted for medical use, food supplements, enzyme food supplements, protein food supplements, protein supplements for animals, by-products of the processing of cereals for dietetic or medical use, biological preparations for medical use, biological preparations for veterinary use, pills for medicines, namely, immunosuppressant pills, chemical preparations for medical use, namely, for the treatment of viral and infectious diseases, for the treatment of cancer, for the prevention and treatment of cancer, for the treatment of immune system related diseases and disorders, chemical preparations for veterinary use, namely, for the treatment of viral and infectious diseases, for the treatment of cancer, for the prevention and treatment of cancer, for the treatment of immune system related diseases and disorders, biological tissue cultures for medical use, biological tissue cultures for veterinary use, enzyme preparations for medical use, enzyme preparations for veterinary use, enzymes for medical use, enzymes for veterinary use, medicines for veterinary use for the treatment of viral and infectious diseases, for the treatment of cancer, for the treatment of immune system related diseases and disorders, for the prevention and treatment of cancer, remedies for veterinary use, namely, monoclonal antibodies for immunomodulatory treatments, vaccines, veterinary products in the nature of anti-infective products for veterinary use; living tissue grafts, surgical implants composed of living tissue, radiological contrast substances for medical use, diagnostic preparations for medical use, biomarker reagents for diagnosis for medical use, adjuvants for medical use, chemical preparations for pharmaceutical use, drugs for medical use, namely, for the treatment of viral and infectious diseases, for the treatment of cancer, for the prevention and treatment of cancer, for the treatment of immune system related diseases and disorders, pharmaceutical preparations, namely, elixirs for treating viral and infectious diseases, for the treatment of cancer, for the prevention and treatment of cancer, for the treatment of immune system related diseases and disorders, plant extracts for pharmaceutical use, medicinal infusions for treating viral and infectious diseases, for treating cancer, for treating immune system related diseases and disorders, for the prevention and treatment of cancer, lotions for pharmaceutical use, medicines or human medicine for the treatment of viral and infectious diseases, for the treatment of cancer, for the treatment of immune system related diseases and disorders, for the prevention and treatment of cancer, remedies for human medicine in the nature of solution for injection for the treatment of viral and infectious diseases, for the treatment of cancer, for the prevention and treatment of cancer, for the treatment of immune system related diseases and disorders, pharmaceutical preparations for skin care, pharmaceutical preparations for the treatment of viral and infectious diseases, for the treatment of cancer, for the prevention and treatment of cancer, for the treatment of immune system related diseases and disorders, syrups for pharmaceutical use for the treatment of viral and infectious diseases, for the treatment of cancer, for the prevention and treatment of cancer, for the treatment of immune system related diseases and disorders
  • GS0101: Surgical, medical, dental and veterinary apparatus and instruments, namely, infusion bag, vial, syringe; needles for medical use, medical apparatus and instruments, containers for applying medicines, namely, infusion bag, vial, syringe, hypodermic syringes, syringes for medical use, pumps for medical use, namely, infusion pump
Case File Event Statements
  • 2/17/2017 - 7 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 2/16/2017 - 7 years ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR
  • 2/25/2017 - 7 years ago
    6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 8/2/2017 - 7 years ago
    12 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 2/17/2017 - 7 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 2/21/2017 - 7 years ago
    4 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 2/24/2017 - 7 years ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 2/28/2017 - 7 years ago
    7 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 2/28/2017 - 7 years ago
    8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 3/18/2017 - 7 years ago
    9 - REFUSAL PROCESSED BY IB Type: RFNT
  • 7/24/2017 - 7 years ago
    10 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 7/24/2017 - 7 years ago
    11 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 8/29/2017 - 7 years ago
    14 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 8/29/2017 - 7 years ago
    15 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 10/4/2017 - 7 years ago
    19 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS
  • 10/24/2017 - 7 years ago
    21 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 10/24/2017 - 7 years ago
    22 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 1/9/2018 - 7 years ago
    23 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 4/9/2018 - 6 years ago
    24 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR
  • 4/16/2018 - 6 years ago
    25 - FINAL DISPOSITION PROCESSED Type: FIMP
  • 8/23/2017 - 7 years ago
    13 - ASSIGNED TO LIE Type: ALIE
  • 9/19/2017 - 7 years ago
    16 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 10/4/2017 - 7 years ago
    17 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 10/4/2017 - 7 years ago
    18 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Type: OP2R
  • 10/21/2017 - 7 years ago
    20 - NOTIFICATION PROCESSED BY IB Type: GPNX
  • 4/16/2018 - 6 years ago
    26 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS
  • 1/9/2023 - 2 years ago
    29 - COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED Type: REM3
  • 7/26/2024 - 5 months ago
    30 - CANCELLED SECTION 71 Type: C71T
  • 12/31/2021 - 3 years ago
    28 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP
  • 6/1/2018 - 6 years ago
    27 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO